IS6653A - Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni - Google Patents
Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efniInfo
- Publication number
- IS6653A IS6653A IS6653A IS6653A IS6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A
- Authority
- IS
- Iceland
- Prior art keywords
- inhibitors
- blend containing
- containing beta
- new blend
- lowering substances
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
PCT/SE2001/001380 WO2001097751A2 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
Publications (1)
Publication Number | Publication Date |
---|---|
IS6653A true IS6653A (is) | 2002-12-11 |
Family
ID=20280209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6653A IS6653A (is) | 2000-06-22 | 2002-12-11 | Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni |
Country Status (28)
Country | Link |
---|---|
US (2) | US20030191177A1 (is) |
EP (1) | EP1296716B1 (is) |
JP (1) | JP2003535875A (is) |
KR (1) | KR20030010750A (is) |
CN (1) | CN1437484A (is) |
AR (1) | AR028699A1 (is) |
AT (1) | ATE344675T1 (is) |
AU (1) | AU2001274766A1 (is) |
BG (1) | BG107373A (is) |
BR (1) | BR0111790A (is) |
CA (1) | CA2411100A1 (is) |
CZ (1) | CZ20024181A3 (is) |
DE (1) | DE60124400T2 (is) |
EE (1) | EE200200703A (is) |
ES (1) | ES2274892T3 (is) |
HK (1) | HK1054508A1 (is) |
HU (1) | HUP0302371A3 (is) |
IL (1) | IL153245A0 (is) |
IS (1) | IS6653A (is) |
MX (1) | MXPA02012957A (is) |
NO (1) | NO20026177L (is) |
NZ (1) | NZ523188A (is) |
PL (1) | PL360484A1 (is) |
RU (1) | RU2271802C2 (is) |
SE (1) | SE0002354D0 (is) |
SK (1) | SK18072002A3 (is) |
WO (1) | WO2001097751A2 (is) |
ZA (1) | ZA200209908B (is) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1722780A4 (en) * | 2003-11-26 | 2008-12-17 | Univ Duke | METHOD FOR PREVENTING OR TREATING GLAUCOMA |
KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
KR100836321B1 (ko) | 2006-10-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 모니터 장치 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
DE69212646T2 (de) * | 1991-03-18 | 1997-03-13 | Sepracor Inc | Zubereitung und verfahren enthaltend optisch reines s-metoprolol |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
NO177455C (no) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Anordning ved apparat for fremstilling av brannslukkende skum |
AU732465B2 (en) * | 1996-04-17 | 2001-04-26 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (sv) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
DE69911058T2 (de) * | 1998-12-23 | 2004-06-03 | G.D. Searle Llc, Chicago | Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen |
-
2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
-
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Application Discontinuation
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 EP EP01941409A patent/EP1296716B1/en not_active Expired - Lifetime
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
-
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
-
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
-
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR028699A1 (es) | 2003-05-21 |
ATE344675T1 (de) | 2006-11-15 |
NO20026177D0 (no) | 2002-12-20 |
ES2274892T3 (es) | 2007-06-01 |
CA2411100A1 (en) | 2001-12-27 |
MXPA02012957A (es) | 2003-05-15 |
NO20026177L (no) | 2002-12-20 |
US20030191177A1 (en) | 2003-10-09 |
US20060252814A1 (en) | 2006-11-09 |
SE0002354D0 (sv) | 2000-06-22 |
EP1296716A2 (en) | 2003-04-02 |
DE60124400T2 (de) | 2007-10-31 |
CN1437484A (zh) | 2003-08-20 |
BR0111790A (pt) | 2003-05-20 |
EE200200703A (et) | 2004-08-16 |
WO2001097751A2 (en) | 2001-12-27 |
HUP0302371A2 (hu) | 2003-11-28 |
WO2001097751A3 (en) | 2002-03-28 |
AU2001274766A1 (en) | 2002-01-02 |
JP2003535875A (ja) | 2003-12-02 |
EP1296716B1 (en) | 2006-11-08 |
RU2271802C2 (ru) | 2006-03-20 |
NZ523188A (en) | 2006-06-30 |
PL360484A1 (en) | 2004-09-06 |
HUP0302371A3 (en) | 2007-03-28 |
IL153245A0 (en) | 2003-07-06 |
DE60124400D1 (de) | 2006-12-21 |
CZ20024181A3 (cs) | 2003-04-16 |
ZA200209908B (en) | 2004-03-05 |
HK1054508A1 (zh) | 2003-12-05 |
SK18072002A3 (sk) | 2003-08-05 |
KR20030010750A (ko) | 2003-02-05 |
BG107373A (bg) | 2003-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23122A (en) | Pyrrolcarboxamides and pyrrolcarbothioamides | |
PL351552A1 (en) | Gypsum compositions and related methods | |
AU9667901A (en) | Mycoattractants and mycopesticides | |
EP1274424A4 (en) | CONNECTIONS AND PROCEDURE | |
GB0026598D0 (en) | Improved drilling methods and apparatus | |
IL152396A0 (en) | New thiochromane derivatives derivatives and their use as thrombin inhibitors | |
IS6693A (is) | Ný efnasambönd og notkun þeirra sem glýsín flutningshindra | |
IS6140A (is) | Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil | |
IS6653A (is) | Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni | |
GB0020363D0 (en) | Detector asssemblies and methods | |
GB0016943D0 (en) | Drills and their manufacture | |
EP1343796A4 (en) | COMPOUNDS AND METHODS | |
GB2373523B (en) | Method and device for rotary well drilling | |
GB0019309D0 (en) | Vane adjusted wingsail | |
AU7815201A (en) | Synthetic salicylihalamides, apicularens and derivatives thereof | |
GB0109036D0 (en) | Microwave-acoustic gas analyzer | |
GB0220776D0 (en) | FOXP2 and uses thereof | |
AU5054501A (en) | Acetyltransferase and uses thereof | |
GB0000859D0 (en) | Oral stereotypies | |
GB0021437D0 (en) | Word line test ability improvement | |
AU3713801A (en) | Animation technology | |
AU4396101A (en) | Perforation detection method | |
AU7035601A (en) | Novel compounds and methods | |
HU0800579D0 (en) | Highly selective norepinephrine reuptake inhibitors and methods using the same | |
GB0008876D0 (en) | IC2CU and IC2IDU |